BetterLife Pharma Inc (CSE:BETR, OTCQB:BETRF), a biotech company focused on the development and commercialization of cutting-edge treatments for mental.
Enveric Biosciences Inc announced the closing of its underwritten public offering that generated gross proceeds of about $10 million. The company intends to.
Enveric Biosciences Inc announced the closing of its underwritten public offering that generated gross proceeds of about $10 million. The company intends to.
BetterLife Pharma Inc (CSE:BETR, OTCQB:BETRF) said it has obtained positive results from a preclinical neural plasticity study of BETR-001 in cortical rat.
Enveric Biosciences Inc announced the closing of its underwritten public offering that generated gross proceeds of about $10 million. The company intends to.